JOHNSON JAMES A

SEC source: 0001225501-26-000003 · form4-06242026_100614.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 28,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

SEC source: 0001225501-26-000002 · form4-04132026_080417.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,000

Underlying: Common Stock · 28,000 shares

Expires 2036-04-08

F1 · derivative.exercise_date: The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.

SEC source: 0001415889-25-015436 · form4-06032025_090605.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,900

Underlying: Common Stock · 20,900 shares

Expires 2035-05-29

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

SEC source: 0001415889-24-014578 · form4-05242024_100557.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,900

Underlying: Common Stock · 20,900 shares

Expires 2034-05-23

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

SEC source: 0001209191-23-031576 · doc4.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,900

Underlying: Common Stock · 20,900 shares

Expires 2033-05-18

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 19, 2024, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 19, 2023. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

SEC source: 0001209191-23-021708 · doc4.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

SEC source: 0001209191-22-032684 · doc4.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,871

Underlying: Common Stock · 13,871 shares

Expires 2032-05-19

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 20, 2023, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 20, 2022. The option reported was granted pursuant to the terms of the Issuer's outside director compensation policy.

SEC source: 0001209191-21-036915 · doc4.xml · derivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,871

Underlying: Common Stock · 13,871 shares

Expires 2031-05-27

F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 28, 2022, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 28, 2021.

SEC source: 0001401708-17-000074 · wf-form4_150464684616298.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,548

F1 · date: The Purchase Period (as defined in the ESPP) ended on September 1, 2017.

F2 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2017 through September 1, 2017. This transaction is also exempt under Rule 16b-3(c).

F3 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2017.

SEC source: 0001209191-17-017103 · doc4.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,954

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of September 1, 2016 through March 1, 2017. This transaction is also exempt under rule 16b-3(c).

F2 · date: The Purchase Period ended on March 1, 2017 and is the first of two Purchase Periods comprising the Offering Period (as defined in the ESPP) that began on March 1, 2016 (the "Enrollment Date").

F3 · shares: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on the Enrollment Date.

F3 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on the Enrollment Date.

SEC source: 0001209191-17-008857 · doc4.xml · derivative · entry 5

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-02-05

F6 · derivative.exercise_date: The shares subject to this option shall vest at a rate of 1/48th of the total number of shares vest on the one-month anniversary of February 6, 2017 (the "Option Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Option Vesting Commencement Date thereafter (and if there is no corresponding day, on the last day of the month) for so long as the recipient of the option remains a "Service Provider" (as defined in the 2013 Plan) of the Company, such that the total number of shares shall be fully vested on the four-year anniversary of the Option Vesting Commencement Date.

SEC source: 0001209191-17-008857 · doc4.xml · derivative · entry 4

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.

F5 · derivative.exercise_date: 1/3 of the RSUs vest on the first market trading day following the first anniversary of March 6, 2017 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

F5 · derivative.expiration_date: 1/3 of the RSUs vest on the first market trading day following the first anniversary of March 6, 2017 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

SEC source: 0001209191-17-008857 · doc4.xml · derivative · entry 3

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,667

Underlying: Common Stock · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: On February 3, 2016, the reporting person was granted 10,000 RSUs, vesting in three equal installments beginning on the first market trading day following the first anniversary of the grant date.

F3 · derivative.expiration_date: On February 3, 2016, the reporting person was granted 10,000 RSUs, vesting in three equal installments beginning on the first market trading day following the first anniversary of the grant date.

SEC source: 0001209191-17-008857 · doc4.xml · nonDerivative · entry 2

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,333

F2 · shares: The reported shares were withheld to cover the reporting person's tax liability in connection with the vesting of RSUs. These shares were not issued to or sold by the reporting person.

SEC source: 0001209191-17-008857 · doc4.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSUs") convert into Common Stock on a one-for-one basis.

SEC source: 0001209191-16-149988 · doc4.xml · derivative · entry 7

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,968

Underlying: Common Stock · 4,391 shares

Expires 2022-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option is subject to an early exercise provision and is immediately exercisable. 25% of the shares subject to the Option vest on the one-year anniversary of October 1, 2012 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement.

SEC source: 0001209191-16-149988 · doc4.xml · nonDerivative · entry 5

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,089

F1 · kind: The sales reported by Mr. Johnson were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2016.

F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-16-149988 · doc4.xml · nonDerivative · entry 4

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-16-149988 · doc4.xml · derivative · entry 6

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,359

Underlying: Common Stock · 5,609 shares

Expires 2022-10-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option is subject to an early exercise provision and is immediately exercisable. 25% of the shares subject to the Option vest on the one-year anniversary of October 1, 2012 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement.

SEC source: 0001209191-16-149988 · doc4.xml · nonDerivative · entry 3

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,089

F1 · kind: The sales reported by Mr. Johnson were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2016.

F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.72 to $22.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-16-149988 · doc4.xml · nonDerivative · entry 2

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,555

F1 · kind: The sales reported by Mr. Johnson were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2016.

F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $21.71 to $22.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-16-149988 · doc4.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,698

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-16-139999 · doc4.xml · nonDerivative · entry 1

JOHNSON JAMES A · CIK 0001225501 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,089

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2016 through September 1, 2016. This transaction is also exempt under rule 16b-3(c).

F2 · date: The Purchase Period ended on September 1, 2016 and is the first of two Purchase Periods comprising the Offering Period (as defined in the ESPP) that began on March 1, 2016 (the "Enrollment Date").

F3 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on the Enrollment Date.